Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Comparative and Clinical Medicine

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1680886

Arbutin protects against methotrexate-induced pulmonary injury in rats via modulation of oxidative stress, inflammation, and ER stress

Provisionally accepted
Nihal  Turkmen AlemdarNihal Turkmen Alemdar1Selim  DemirSelim Demir2*Esin  YulugEsin Yulug2Nadire  Sevdenur ErdoganNadire Sevdenur Erdogan2Elif  Ayazoglu DemirElif Ayazoglu Demir2Ahmet  MenteşeAhmet Menteşe2Yuksel  AliyaziciogluYuksel Aliyazicioglu2
  • 1Recep Tayyip Erdogan Universitesi, Rize, Türkiye
  • 2Karadeniz Technical University, Trabzon, Türkiye

The final, formatted version of the article will be published soon.

Introduction: Methotrexate (MTX) is a widely utilised agent in the treatment of cancer, yet it is notable that it can induce pulmonary toxicity in cases of high-dose chemotherapy. Arbutin (ARB) is a hydroquinone compound that is present in members of the Lamiaceae, Ericaceae and Rosaceae families, and experimental studies have demonstrated its capacity for lung protection. The present study aimed to determine whether ARB could reduce the pulmonary toxicity of MTX and to explore the underlying mechanisms. Methods: The lung toxicity rat model was created by means of a single intraperitoneal injection of MTX at a dose of 20 mg/kg. The animals were then treated with two different doses of ARB (50 and 100 mg/kg) for a period of seven days. Following the conclusion of the treatment period, a histopathological examination of the lung tissue samples was conducted. The remaining tissue samples were evaluated for oxidative stress (OS), inflammation, endoplasmic reticulum stress (ERS), sirtuin 1 (SIRT1)/nuclear factor erythroid-related factor 2 (Nrf2) pathway, and apoptosis for further analysis. Results: The administration of MTX resulted in the inhibition of SIRT1/Nrf2 in lung tissue, accompanied by an escalation in OS, inflammation, ERS, and apoptosis levels. This was concomitant with a significant enhancement in the severity of histopathological findings. Nevertheless, ARB reversed MTX-induced biochemical and pathological changes through SIRT1/Nrf2 modulation. Discussion: It is asserted that further comprehensive studies are required to support the hypothesis that ARB has the potential to improve oxidative and inflammatory lung injury via SIRT1/Nrf2 modulation.

Keywords: Arbutin, Endoplasmic Reticulum Stress, Methotrexate, Nrf2, Pulmonary toxicity, SIRT1

Received: 06 Aug 2025; Accepted: 06 Oct 2025.

Copyright: © 2025 Turkmen Alemdar, Demir, Yulug, Erdogan, Ayazoglu Demir, Menteşe and Aliyazicioglu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Selim Demir, selim-demir@hotmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.